HIV-1 genetic subtypes and antiretroviral therapy resistance testing

被引：0
作者：
Galpin, S [1 ]
Beddows, S [1 ]
Johargy, A [1 ]
Ashraf, A [1 ]
Prater, AJ [1 ]
White, N [1 ]
Clarke, J [1 ]
McClure, M [1 ]
Weber, JN [1 ]
机构：
[1] St Marys Hosp, Dept Genitourinary Med, Jefferiss Res Trust Labs, Imperial Coll Sch Med, London W2 1PG, England
来源：
AIDS | 2000年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P350
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [21] HIV-1 Antiretroviral Drug Therapy
    Arts, Eric J.
    Hazuda, Daria J.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (04):
  • [22] HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes
    Reigadas, S.
    Marcelin, A. G.
    Houssaini, A.
    Yerly, S.
    Descamps, D.
    Plantier, J. C.
    Ruffault, A.
    Amiel, C.
    Trabaud, M. A.
    Flandre, Philippe
    Fleury, H.
    Masquelier, B.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (04) : 969 - 972
  • [23] Relationship of Injection Drug Use, Antiretroviral Therapy Resistance, and Genetic Diversity in the HIV-1 pol Gene
    Kowalski, Jeanne
    Gange, Stephen J.
    Schneider, Michael F.
    Tsai, Hua-Ling
    Templeton, Alan
    Shao, Qiujia
    Zhan, Guang Wen
    Yeh, Mei-Fen
    Young, Mary
    Markham, Richard. B.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (04) : 381 - 389
  • [24] ZIDOVUDINE RESISTANCE AND HIV-1 DISEASE PROGRESSION DURING ANTIRETROVIRAL THERAPY
    DAQUILA, RT
    JOHNSON, VA
    WELLES, SL
    JAPOUR, AJ
    KURITZKES, DR
    DEGRUTTOLA, V
    REICHELDERFER, PS
    COOMBS, RW
    CRUMPACKER, CS
    KAHN, JO
    RICHMAN, DD
    ANNALS OF INTERNAL MEDICINE, 1995, 122 (06) : 401 - 408
  • [25] Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes
    Holguin, Africa
    Ramirez de Arellano, Eva
    Rivas, Pablo
    Soriano, Vincent
    AIDS REVIEWS, 2006, 8 (02) : 98 - 107
  • [26] Diverse HIV-1 genetic subtypes in UK
    Clewley, JP
    Arnold, C
    Barlow, KL
    Grant, PR
    Parry, JV
    LANCET, 1996, 347 (9013) : 1487 - 1487
  • [27] Selection of resistance following first-line antiretroviral regimens among HIV-1 subtypes
    Kantor, R
    DeLong, A
    Shafer, RW
    Carvalho, AP
    Wynhoven, B
    Cane, P
    Sirivichayakul, S
    Soares, MA
    Snoeck, J
    Rudich, H
    Rodrigues, R
    Holguin, A
    Ariyoshi, K
    Bouzas, MB
    Cahn, P
    Sugiura, W
    Soriano, V
    Brigido, LF
    Grossman, Z
    Morris, L
    Vandamme, AM
    Tanuri, A
    Phanuphak, P
    Weber, J
    Pillay, D
    Harrigan, PR
    Camacho, R
    Schapiro, JM
    Hogan, J
    Katzenstein, DA
    ANTIVIRAL THERAPY, 2005, 10 (04) : S146 - S146
  • [28] Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection
    Chamberland, A.
    Sylla, M.
    Boulassel, M. R.
    Baril, J-G
    Cote, P.
    Thomas, R.
    Trottier, B.
    Rouleau, D.
    Routy, J-P
    Tremblay, C.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2011, 22 (03) : 146 - 150
  • [29] Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy & vaccine development
    Lal, RB
    Chakrabarti, S
    Yang, CF
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2005, 121 (04) : 287 - 314
  • [30] Differential first-line antiretroviral therapy resistance in HIV-1 non-B subtypes in India, China and Thailand
    Huang, A.
    Katzenstein, D. A.
    Saravanan, S.
    Wu, Y.
    Sirivichayakul, S.
    Kumarasamy, N.
    Zhang, F.
    Phanuphak, P.
    Kantor, R.
    ANTIVIRAL THERAPY, 2013, 18 : A75 - A75
12345